Gabriele Fischer is medical director of the Addiction Clinic, Department of Psychiatry & Psychotherapy, MUV, where substance use disorders and non-substance dependent patients (e.g. pathological gamblers) are treated in addition to a variety of research programs, with a double-assignment to the Center for Public Health. As a scientist she has more than 140 peer-reviewed scientific publications and is consultant of WHO & UN and board member of the scientific committee of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). G. Fischer has been involved in comprehensive international research co-operations and is a member of multiple international scientific associations.
Highlighted Session – Gabriele Fischer
Click for Bio
